Press release
Biomarkers Summit
SMi's 4th annual Biomarkers Summit, 31st January & 1st February, 2011, London, UK.
On Wednesday February 2nd, we will also be hosting an interactive post-conference workshop entitled:
Fit for Purpose Biomarkers: From Bench to Bedside
Hosted by: Eric Culbert, Executive Consultant, BioScience Innovations.
In association with: BioScience Innovations
This highly interactive workshop will highlight the nature and requirements of the different classes of biomarkers, the technologies most suited to developing biomarkers, and discuss case studies of biomarker development and implementation which will help illuminate the key issues which can arrive during the journey from bench to bedside.
To keep up to date with this event and workshop visit:
www.smi-online.co.uk/preclinical-biomarkers.asp
Program Overview – Topics & Speakers
Biomarkers In Oncology
Peter Smith, Senior Scientist II, Oncology, Millennium Pharmaceuticals
Robert Wilkinson, Principal Scientist II, AstraZeneca
Metodi Metodiev, Director of Proteomics Unit, University of Essex
Mathias Dreger, Head of Biochemistry, Caprotec
Huseyin Mehmet, Director of Exploratory Biomarkers, Diabetes, Merck
Fernando Ulloa-Montoya, Head of Molecular Biology Technology Group, GlaxoSmithKline Biologicals
Hans Winkler, Senior Director and Global Head, Oncology Biomarkers, Johnson & Johnson
Karen Asin, Director, Translational Pharmacology, Takeda
Patrick Murray, Professor of Clinical Pharmacology, University College Dublin (UCD)
Biomarkers in Immunology & CNS
Andrew Payne, Senior Group Leader, Cellular Sciences, UCB
Mark Fidock, Associate Research Fellow, Head of Quantitative Biomarkers, Pfizer
Matthew Albert, Director of Immunology, Institut Pasteur
Iain Kilty, Director Allergy and Respiratory Research Unit, Pfizer
Sabine Küsters, Director of Scientific Relations, Rules Based Medicine
Thomas Joos, Head of Biochemistry, Natural and Medical Sciences Institute (NMI)
Mette Jensen, Translational Medicine Scientist, Lundbeck
Jennifer Larsen, Translational Medicine Scientist, Lundbeck
Jens Mikkelsen, Professor, Neurosearch A/S
Biostatistics
Ziad Taib, Statistical Science Director, Astrazeneca
Ann Hastings, Translational Scientist, Astellas
Hugh Salter, Principal Scientist, Astrazeneca
Andreas Schuppert, Director, Bayer Technology Services / RWTH Aachen University
Personalised Medicine
Louise Leong, Head of R&D, Association of the British Pharmaceutical Industry (APBI)
Hayley Whitaker, Research Associate, Biomarkers, Cancer Research UK / University Of Cambridge
Ge Ruigt, Director Experimental Medicine Neuroscience, Merck
Shawnmarie Mayrand-Chung, Program Director, Biomarkers Consortium, National Institutes of Health (NIH)
Jean-Luc Sanne, Scientific Officer, European Commission's Research Directorate General
SPONSORSHIP & EXHIBITION INFORMATION
SMi Group offer excellent opportunities to profile your company through tailored sponsorship and branding packages.
Alia Malick tel: +44 (0) 20 7827 6168 email: amalick@smi-online.co.uk
TO BOOK
DELEGATE BOOKINGS
Zain Philbey tel: +44 (0) 20 7827 6722 email: zphilbey@smi-online.co.uk
Please visit www.smi-online.co.uk/preclinical-biomarkers.asp
Supported by: b3c Newswire, Bentham Science, Biocompare, Biomarkers in Medicine, BioMEV, BioNMD, Biotechniques, Business Monitor International, Canbiotech, Drug Discovery Today, European Life Sciences, Future Drugs, Going to Meet, Health Economics, Inpharm.com, Labroots, Medchem.com, Metabolomics.net, PharmaPhorum, PharmaVoice, Pharmcast, PMR, Report Buyer, SelectsScience.net, Technology Networks, Translational Biomedicine
SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.
SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments.
SMi Group Ltd,
Unit 122, Great Guildford Business Square,
30 Great Guildford Street,
London, SE1 0HS,
United Kingdom.
Tel: +44 (0) 20 7827 6000
Fax: +44 (0) 20 7827 6001
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Summit here
News-ID: 154487 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Biomarker
Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF (including full…
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the…
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period.
A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis…
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core…
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports.
The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and…
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological…
